(Q39077133)

8 September 2017

title

Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery (English)

1 reference

8 September 2017

1 reference

Zhigang Xu

1

1 reference

8 September 2017

Dongdong Wang

2

1 reference

8 September 2017

Shuang Xu

3

1 reference

8 September 2017

Xiaoyan Liu

4

1 reference

8 September 2017

Xiaoyu Zhang

5

1 reference

8 September 2017

Haixia Zhang

6

1 reference

8 September 2017

publication date

17 October 2013

1 reference

Chemistry - An Asian Journal

8 September 2017

published in

1 reference

8 September 2017

volume

9

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

199-205

1 reference

Design and development of polymer conjugates as anti-angiogenic agents

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Gold nanocluster-conjugated amphiphilic block copolymer for tumor-targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Fine-tuning the pH trigger of self-assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

pH-sensitive chitosan-derived nanoparticles as doxorubicin carriers for effective anti-tumor activity: preparation and in vitro evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Enzyme-responsive nanoparticles for drug release and diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Click and photo-unclick chemistry of aminoacrylate for visible light-triggered drug release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

A phenylboronate-functionalized polyion complex micelle for ATP-triggered release of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Norbornene derived doxorubicin copolymers as drug carriers with pH responsive hydrazone linker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Polymer conjugates as anticancer nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

PEGylation, successful approach to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Self-Cross-Linked Polymer Nanogels: A Versatile Nanoscopic Drug Delivery Platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

N-(2-hydroxypropyl)methacrylamide copolymers of a glutathione (GSH)-activated glyoxalase i inhibitor and DNA alkylating agent: synthesis, reaction kinetics with GSH, and in vitro antitumor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Preparation of copolymer paclitaxel covalently linked via a disulfide bond and its application on controlled drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Synthesis of disulfide-cross-linked polypeptide nanogel conjugated with a near-infrared fluorescence probe for direct imaging of reduction-induced drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Neuron-targeted copolymers with sheddable shielding blocks synthesized using a reducible, RAFT-ATRP double-head agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Supramolecular nanostructures formed by anticancer drug assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Hepatocyte-targeting single galactose-appended naphthalimide: a tool for intracellular thiol imaging in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Photoluminescent silicon nanocrystal-based multifunctional carrier for pH-regulated drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Biodegradable luminescent porous silicon nanoparticles for in vivo applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Chitosan-based responsive hybrid nanogels for integration of optical pH-sensing, tumor cell imaging and controlled drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Cytotoxicity of a unimolecular polymeric micelle and its degradation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

Pegylation: engineering improved pharmaceuticals for enhanced therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FASIA.201301030

21 January 2018

Identifiers

DOI

10.1002/ASIA.201301030

1 reference

8 September 2017

1 reference